LAURUS LABS LTD
LAURUSLABS.NS
₹ 438.60
3%

Laurus Labs Ltd

Laurus Labs Ltd is a Small Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of Laurus Labs is ₹ 438.60 that is ₹ 11.30 -2.51% with respect to the previous day’s close price. The stock price of Laurus Labs was last updated 14 hours ago.

Laurus Labs Stock Price Performance

In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.

Laurus Labs Live Share Price Analysis

LAURUS LABS LTD
₹ 438.60
Open ₹ 448.05
High ₹ 450.65
Marketcap 236.39B
Close ₹ 438.60
Low ₹ 430.50
Volume ₹ 3,640,231.00

The stock of Laurus Labs Ltd strated the trade at an Open price of ₹ 448.05 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 450.65 and an Intraday Low price of ₹ 430.50%. As per last updated 14 hours ago, the Shares of Laurus Labs were trading at a price of ₹ 438.60 which is ₹ 11.30 -2.51% as compared the price ₹ 449.90 at which the stock close on the previous trading day. The total traded volume for the day stood at 3,640,231 number of shares.

Candlestick Chart of Laurus Labs Share Price Movements

The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).

Historical Performance of Laurus Labs Shares

52 Week RangePrice52 Weeks Low52 Weeks High
₹ 438.60₹ 325.30₹ 471.00

Here is Laurus Labs’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 471.00. On the lower side, the stock has been to the 52 weeks low price level of ₹ 325.30. It’s last traded price was ₹ 438.60 as on last update 14 hours ago. The one-year line chart clearly shows how the price of Laurus Labs’s stock has moved in the last twelve months.

The Company has posted an earnings of ₹ 2.97 per share (EPS TTM) in the trailing twelve months period. Laurus Labs’s last annual dividend rate was 0.8%, which translates to a 0.18% of annual dividend yield.

Line Chart of Laurus Labs Stock Price

Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.

Companies Similar to Laurus Labs

Laurus Labs Ltd belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Laurus Labs are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.

Share Price Snapshot Companies Similar to Laurus Labs

Select list of companies is given below. To view more about the Industry and see other companies from Industry, click on the industry name.
ALEMBICLTD.NSALEMBIC LTD
₹ 103.35
NSE
₹ 2.55
2.41%

About Laurus Labs

Laurus Labs Ltd is a Private Company. The company operates in the Pharmaceuticals & Drugs sector. It is an India-based manufacturer of active pharmaceutical ingredietns (APIs) for anti-etrovirals (ARVs), oncology, cardiovascular, anti-diabetics, anti-asthma and gastroenterology. Incorporated in 2005, it has around 16 years of operations. Laurus Labs live share price is ₹ 438.60. It is a Small Cap stock and had a market capitalization of ₹ 236,390,498,304.00 as on 14 hours ago.

  • Laurus Labs develops and manufactures oral solid formulations, provides contract research and manufacturing services (CRAMS) and contract development and manufacturing organization (CDMO) to the global pharmaceutical companies.
  • The Company also produces specialty ingredients for nutraceuticals, dietary supplements, and cosmeceuticals.
  • Its business units include Generics APIs, Generics Finished Dosage Forms (FDFs) and Synthesis/Ingredients.
  • The Generics APIs business comprises the development, manufacture and sale of APIs and advanced intermediates in the ARV, Hepatitis C, oncology, cardiovascular, anti-diabetic, anti-asthmatic, gastroenterology and ophthalmic therapeutic areas.
  • The Generics FDFs is engaged in developing and manufacturing oral solid formulations.

The registered office of Laurus Labs is located in Vishakhapatnam, Andhra Pradesh. The registrar and share transfer agent for Laurus Labs is K FIN Technologies Pvt Ltd. The Stock Exchanges on which shares of Laurus Labs Ltd is listed includes BSE, NSE.

LAURUS LABS LTD
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 5753
Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
AddressSerene Chambers, Hyderabad, India
CountryIndia
Phone91 40 3980 4333
Websitehttps://www.lauruslabs.com

Laurus Labs Recent News

No Recent News found for Laurus Labs Ltd.